Clinical applications of TNF-α in cancer

This publication has 36 references indexed in Scilit:

• Feasibility and Efficacy of External Beam Radiotherapy after Hyperthermic Isolated Limb Perfusion with TNF-α and Melphalan for Limb-saving Treatment in Locally Advanced Extremity Soft-tissue Sarcoma
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Side effects of cancer treatment with recombinant human tumour necrosis factor alpha: a new challenge for the intensive care unit
  Clinical Intensive Care, 1997
• Treatment of in-transit melanoma metastases with tumour necrosis factor (TNF-??) and chemotherapy administered in isolated limb perfusion (ILP)
  Melanoma Research, 1997
• What is the best regional therapy?
  Melanoma Research, 1997
• Hyperthermic antiblastic perfusion with TNF-Alpha and L.Pam in patients with stage II, IIIA and IIIAB limb melanoma
  Melanoma Research, 1997
• Effects of Hyperthermic Isolated Limb Perfusion with Tumor Necrosis Factor-?? and Melphalan on Pulmonary Function Assessments
  Journal of Immunotherapy, 1997
• Effects of isolated limb perfusion with tumour necrosis factor-alpha on the function of monocytes and T lymphocytes in patients with cancer
  European Journal of Clinical Investigation, 1996
• Transient Induction of E-Selectin Expression Following TNFα-Based Isolated Limb Perfusion in Melanoma and Sarcoma Patients Is Not Tumor Specific
  Journal of Immunotherapy, 1996
• Rapid increase in plasma tenascin‐C concentration after isolated limb perfusion with high‐dose tumor necrosis factor (TNF), interferon gamma (IFNγ) and melphalan for regionally advanced tumors
  International Journal of Cancer, 1995
• High dose recombinant tumour necrosis factor (rTNFα) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer
  European Journal Of Cancer, 1995